| |
| |
|
| Insider
Information: |
Nash Huw M. |
| Relationship: |
|
| City: |
Bedford |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stoke Therapeutics, Inc. |
STOK |
|
2024-05-20 |
0 |
2020-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2024-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,100 |
15,445 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2021-06-01 |
4 |
OE |
$2.19 |
$1,259 |
D/D |
575 |
575 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2021-01-06 |
4 |
AS |
$57.14 |
$1,828 |
D/D |
(32) |
0 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-07-16 |
4 |
OE |
$2.19 |
$4,161 |
D/D |
1,900 |
1,900 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2021-11-03 |
4 |
OE |
$2.19 |
$4,161 |
D/D |
1,900 |
1,900 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-08-28 |
4 |
OE |
$2.19 |
$4,557 |
D/D |
2,081 |
2,081 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-06-01 |
4 |
OE |
$2.19 |
$4,614 |
D/D |
2,107 |
2,107 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-12-18 |
4 |
OE |
$0.60 |
$4,809 |
D/D |
8,015 |
8,015 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-07-01 |
4 |
OE |
$2.19 |
$8,322 |
D/D |
3,800 |
3,800 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2021-11-01 |
4 |
OE |
$2.19 |
$8,322 |
D/D |
3,800 |
3,800 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2022-01-03 |
4 |
OE |
$2.19 |
$8,322 |
D/D |
3,800 |
3,800 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-08-03 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,700 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-09-01 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,700 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-10-01 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,700 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-11-02 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,700 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-12-01 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,700 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2021-01-04 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,732 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2021-07-01 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,700 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2021-08-02 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,700 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2021-09-01 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,700 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2021-10-01 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,700 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2021-12-01 |
4 |
OE |
$2.19 |
$12,483 |
D/D |
5,700 |
5,700 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2024-04-01 |
4 |
OE |
$0.40 |
$20,000 |
D/D |
50,000 |
61,329 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2024-05-20 |
4 |
OE |
$0.40 |
$20,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
COO & CBO |
• – – |
2020-07-07 |
4 |
AS |
$22.41 |
$20,457 |
D/D |
(913) |
0 |
0 |
- |
|
58 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
